Poly(A)-binding protein
Poly(A)-binding protein (PAB or PABP)
Structure
Cytosolic poly-A binding protein (PABPC) is made up of four
The PABC domain is approximately 75 amino acids and consists of 4 or 5 α-helices depending on the organism – human PABCs have 5, while
The structure of human poly(A)-binding protein found in the nucleus (PABPN1) has yet to be well determined but it has been shown to contain a single RRM domain and an arginine rich carboxy terminal domain. They are thought to be structurally and functionally different from poly-A binding proteins found in the cytosol.
Expression and binding
The expression of mammalian poly(A)-binding protein is regulated at the translational level by a feed-back mechanism: the mRNA encoding PABP contains in its 5'
The cytosolic isoform of eukaryotic poly(A)-binding protein binds to the initiation factor
Rotavirus NSP3
Once rotavirus infection occurs viral GACC-tailed mRNAs are translated while the poly(A)-tailed mRNA is severely impaired. In infected cells, there have been high magnitudes of both translation induction (GACC-tailed mRNA) and reduction (poly(A)-tailed mRNA) both dependent on the rotavirus strain. These data suggest that NSP3 is a translational surrogate of the PABP-poly(A) complex; therefore, it cannot by itself be responsible for inhibiting the translation of host poly(A)-tailed mRNAs upon rotavirus infection.[11]
PABP-C1 evicted from eIF4G by NSP3 accumulates in the nucleus of rotavirus-infected cells. This eviction process requires rotavirus NSP3, eIF4G, and RoXaN. To better understand the interaction, modeling of the NSP3-RoXaN complex, demonstrates mutations in NSP3 interrupt this complex without compromising NSP3 interaction with eIF4G. The nuclear localization of PABP-C1 is dependent on the capacity of NSP3 to interact with eIF4G and also requires the interaction of NSP3 with a specific region in RoXaN, the leucine- and aspartic acid-rich (LD) domain. RoXaN is identified as a cellular partner of NSP3 involved in the nucleocytoplasmic localization of PABP-C1.[12]
Associated diseases
OPMD
Oculopharyngeal muscular dystrophy (OPMD) is a genetic condition that occurs in adulthood often after the age of 40. This disorder usually leads to weaker facial muscles oftentimes showing as progressive eyelid drooping, swallowing difficulties, and proximal limb muscle weakness such as weak leg and hip muscles. People with this disorder are often hindered to the point that they have to use a cane in order to walk.[13] OPMD has been reported in approximately 29 countries and the number affected varies widely by specific population. The disease can be inherited as an autosomal dominant or recessive trait.[14]
Mutations
Mutations in PABPN1 that cause this disorder, result when the protein has an extended polyalanine tract (12-17 alanines long vs. the expected amount of 10). The extra alanines cause PABPN1 to aggregate and form clumps within muscles because they are not able to be broken down. These clumps are believed to disrupt the normal function of
Studies
As of November 2015, significant effort has been dedicated to researching OPMD and potential treatment methods. Myoblast Transplantation has been suggested and is in fact in clinical trials in France. This is done by taking
Genes
Multiple human genes encode different protein isoforms and paralogs of PABP, including PABPN1, PABPC1, PABPC3, PABPC4, PABPC5.[18]
References
- PMID 15630022.
- ^ Poly(A)-Binding+Proteins at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- PMID 5288383.
- PMID 4718742.
- ^ "UniProtKB - Q86U42 (PABP2_HUMAN)". uniprot.org. Retrieved 17 November 2015.
- ^ Voet D, Voet J. Biochemistry (4th ed.). Wiley. p. 1304.
- PMID 10499800.
- PMID 23424172.
- PMID 15355595.
- PMID 9755181.
- PMID 26063427.
- PMID 18799579.
- ^ "Oculopharyngeal muscular dystrophy". Genetics Home Reference. National Library of Medicine.
- ^ "Oculopharyngeal Muscular Dystrophy". National Organization for Rare Disorders.
- ^ Shoubridge C (2000). "Polyalanine Tract Disorders and Neurocognitive Phenotypes". Madame Curie Bioscience Database.
- PMID 16642034.
- ^ "Research and Outcomes". University of New Mexico, School of Medicine.
- ^ PABPC5. HUGO Gene Nomenclature Committee. Accessed 8 April 2020.